Results 21 to 30 of about 124,836 (164)

Agreement between physicians and non-physician clinicians in starting antiretroviral therapy in rural Uganda

Human Resources for Health, 2009
Background The scarcity of physicians in sub-Saharan Africa – particularly in rural clinics staffed only by non-physician health workers – is constraining access to HIV treatment, as only they are legally allowed to start antiretroviral therapy in the ...
Vasan Ashwin, Kenya-Mugisha Nathan, Seung Kwonjune J, Achieng Marion, Banura Patrick, Lule Frank, Beems Megan, Todd Jim, Madraa Elizabeth   +8 more
doaj   +1 more source

Benchmarks for antiretroviral therapy [PDF]

Journal of Clinical Investigation, 2000
Sharp declines in HIV-related morbidity and mortality over the last 4 years are due in part to a fuller understanding of the pathogenesis of HIV infection, the availability of sensitive assays that measure viral replication in vivo, and the use of combinations of antiretroviral drugs that profoundly suppress viral replication for prolonged periods (i.e.
O J, Cohen, A S, Fauci
openaire   +2 more sources

Survival rate of HIV-infected children after initiation of the antiretroviral therapy and its predictors in Ethiopia: A facility-based retrospective cohort

SAGE Open Medicine, 2019
Objective: To determine the survival rate and predictors of HIV-infected children on antiretroviral therapy at two selected facilities in North Ethiopia.
Getachew Arage, Mekonnen Assefa, Teshager Worku, Agumasie Semahegn   +3 more
doaj   +1 more source

Factors of Loss to Follow-up Antiretroviral Therapy in Islanded Area

Unnes Journal of Public Health, 2018
Loss to follow-up of antiretroviral therapy is when PLWHA (People Living with HIV/AIDS) do not come for antiretroviral therapy for more than 3 months. This study aimed to determine the factors of loss to follow-up antiretroviral therapy for PLWHA at Prof.
Thomas Laga Boro, Rafael Paun, Marthen R Pellokila   +2 more
doaj   +1 more source

Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi. [PDF]

PLoS ONE, 2013
Smear-positive pulmonary TB is the most infectious form of TB. Previous studies on the effect of HIV and antiretroviral therapy on TB treatment outcomes among these highly infectious patients demonstrated conflicting results, reducing understanding of ...
Hannock Tweya, Caryl Feldacker, Sam Phiri, Anne Ben-Smith, Lukas Fenner, Andreas Jahn, Mike Kalulu, Ralf Weigel, Chancy Kamba, Rabecca Banda, Matthias Egger, Olivia Keiser   +11 more
doaj   +1 more source

Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016. [PDF]

PLoS ONE, 2018
INTRODUCTION:Antiretroviral therapy reduces the risk of serious illness among people living with HIV and can prevent HIV transmission. We implemented a Test, Treat, and Prevent HIV Program among men who have sex with men (MSM) and transgender women at ...
Sumet Ongwandee, Cheewanan Lertpiriyasuwat, Thana Khawcharoenporn, Ploenchan Chetchotisak, Ekkachai Thiansukhon, Niramon Leerattanapetch, Banlang Leungwaranan, Chomnad Manopaiboon, Thanongsri Phoorisri, Prin Visavakum, Bongkoch Jetsawang, Monsicha Poolsawat, Somboon Nookhai, Monthinee Vasanti-Uppapokakorn, Samart Karuchit, Chonticha Kittinunvorakoon, Philip Mock, Dimitri Prybylski, Ake-Chittra Sukkul, Thierry Roels, Michael Martin   +20 more
doaj   +1 more source

Cervical cancer screen-and-treat services at HIV treatment sites in Nigeria: findings from the ICON-3 Practice Based Research Network

BMC Health Services Research
Background Cervical cancer remains a major public health concern in Nigeria, particularly among women living with HIV (WLHIV). While treatable if detected early, many WLHIV do not access cervical cancer screening and treatment services.
Chibuike O. Chigbu, Cyril C. Dim, Stanley C. Eneh, Babayemi O. Olakunde, John O. Olawepo, Tonia C. Onyeka, Ijeoma U. Itanyi, Ngozi Idemili-Aronu, Nwamaka N. Lasebikan, Chinenye Bembir, Esther Audu, Omeje Ejiofor, Nicholas Hamman, Sagir Muhammad, Atakulu Lawrence, Odufunke Maijeh, Onyeji John, Idayat Yinusa, Bala Barka, Aisha Abdulrahmeen, Ezechukwu Paschalina, Obuchuku Nwafor, Gregory A. Aarons, Echezona E. Ezeanolue   +23 more
doaj   +1 more source

Magnitude of antiretroviral treatment failure and associated factors among adult HIV-positive patients in Harar public hospitals, Eastern Ethiopia

SAGE Open Medicine, 2020
Background: Antiretroviral treatment failure occurred when the antiretroviral regimen is unable to control HIV infection. There is no information on antiretroviral therapy failure in this study area.
Rahel Feleke, Biftu Geda, Kedir Teji Roba, Fitsum Weldegebreal   +3 more
doaj   +1 more source

The Quality of Life of Patients with HIV/AIDS Undergoing Antiretroviral Therapy: A Systematic Review

Jurnal Ners, 2019
Introduction: Quality of Life (QoL) is one of the most important things for a patient with HIV/AIDS. Good QoL will improve the adherence to treatment, especially antiretroviral therapy.
Putri Irwanti Sari, RTS Netisa Martawinarti, Nurmawati S. Lataima, Vivi Meiti Berhimpong   +3 more
doaj   +1 more source

Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age

Brazilian Journal of Infectious Diseases, 2014
Toxicity is the most frequently reported reason for modifying or discontinuing the first combined antiretroviral therapy regimens, and it can cause significant morbidity, poor quality of life and also can be an important barrier to adherence, ultimately ...
Thiago Silva Torres, Sandra Wagner Cardoso, Luciane S. Velasque, Valdilea G. Veloso, Beatriz Grinsztejn   +4 more
doaj   +1 more source